Brendan Smith
Stock Analyst at TD Cowen
(0.29)
# 4,476
Out of 4,479 analysts
4
Total ratings
33.33%
Success rate
-13.08%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVAX Novavax | Maintains: Hold | $5 → $10 | $12.97 | -22.90% | 1 | May 13, 2024 | |
| HALO Halozyme Therapeutics | Initiates: Outperform | $54 | $51.30 | +5.26% | 1 | Feb 29, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Outperform | n/a | $25.22 | - | 1 | Jul 21, 2023 | |
| DNLI Denali Therapeutics | Initiates: Outperform | n/a | $21.74 | - | 1 | Dec 5, 2022 |
Novavax
May 13, 2024
Maintains: Hold
Price Target: $5 → $10
Current: $12.97
Upside: -22.90%
Halozyme Therapeutics
Feb 29, 2024
Initiates: Outperform
Price Target: $54
Current: $51.30
Upside: +5.26%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $25.22
Upside: -
Denali Therapeutics
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $21.74
Upside: -